Product Information
CABERGOLINE 0.5 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $1.4462 per EA under NDC 50742011808. Its NADAC has been published 400 times since Oct 31, 2018.
Strength
.5 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742011808
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CABERGOLINEApproval Type
Generic (ANDA)
FDA Application
ANDA204735On Market Since
8/9/2018
Pharmacological Classes
Price Statistics
The NADAC for CABERGOLINE 0.5 MG TABLET has been published 400 times since Oct 31, 2018, and over the history we have for it it has declined 69.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4462 per EA |
|---|---|
| All-time high | $4.9905 (Apr 10, 2019) |
| All-time low | $1.0692 (Nov 20, 2024) |
| 52-week high | $1.6003 |
| 52-week low | $1.3567 |
| Median price | $2.0796 |
| Average price | $2.2001 |
| Largest weekly change | +45.5% (Nov 18, 2020) |
| Weeks tracked | 400 |
| Tracking since | Oct 31, 2018 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CABERGOLINE 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CABERGOLINE 0.5 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $1.4462 per EA (NDC 50742011808), effective Jun 24, 2026.
How has the price of CABERGOLINE 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CABERGOLINE 0.5 MG TABLET has declined 69.4%. It has been tracked across 400 weekly CMS publications since Oct 31, 2018.
What are the highest and lowest recorded NADAC prices for CABERGOLINE 0.5 MG TABLET?
Since Oct 31, 2018, the NADAC for CABERGOLINE 0.5 MG TABLET has ranged from a low of $1.0692 (Nov 20, 2024) to a high of $4.9905 (Apr 10, 2019), with a median of $2.0796 per EA.
Are there cheaper alternatives to CABERGOLINE 0.5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CABERGOLINE 0.5 MG TABLET, but none are currently priced below it.
Who manufactures CABERGOLINE 0.5 MG TABLET?
CABERGOLINE 0.5 MG TABLET (NDC 50742011808) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification